Bottom line
ZHOK vs XLV: the short answer
ZHOK (SPDR Solactive Hong Kong ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
Updated Nov 19, 2026
ZHOK vs XLV side by side
| ZHOK | XLV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | SPDR (State Street) |
| Category | Other | Health Care Sector |
| Expense ratio | — | 0.08% |
| Annual cost per $10k | — | $8 |
| 10-yr cost on $10k (prospectus) | — | $103 |
| Max front load | None | None |
| 12b-1 fee | — | 0.02% |
| 1-yr return | — | +14.5% |
| 5-yr return (annualized) | — | +8.1% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | — | +14.5% |
| Worst quarter | — | −12.7% |
| Net assets (fund) | — | $40.6B |
| Number of holdings | — | 65 |
| Portfolio turnover | — | 2% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
ZHOK and XLV share none of their top holdings.
ZHOK top 10
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between ZHOK and XLV?
ZHOK (SPDR Solactive Hong Kong ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
Should I own both ZHOK and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.